Promoting access to COVID-19 convalescent plasma in low-and middle-income countries
Low-and middle-income countries (LMICs) remain neglected in the Coronavirus 19 (COVID-
19) pandemic. COVID-19 convalescent plasma (CCP)(ie plasma collected from individuals
after their recovery from COVID-19) has emerged as a leading medical treatment for COVID-
19. Studies to date support the safety—and increasingly the efficacy—of CCP to treat COVID-
19. This has motivated large-scale procurement and transfusion of CCP, notably in the
United States (US), where inventories of CCP have been attained, and government …
19) pandemic. COVID-19 convalescent plasma (CCP)(ie plasma collected from individuals
after their recovery from COVID-19) has emerged as a leading medical treatment for COVID-
19. Studies to date support the safety—and increasingly the efficacy—of CCP to treat COVID-
19. This has motivated large-scale procurement and transfusion of CCP, notably in the
United States (US), where inventories of CCP have been attained, and government …
